Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017

Shigehisa Fumino, Tatsuro Tajiri, Noriaki Usui, Masanori Tamura, Haruhiko Sago, Shigeru Ono, Shunsuke Nosaka, Akihiro Yoneda, Ryota Souzaki, Mayumi Higashi, Kohei Sakai, Ken Takahashi, Takahiro Sugiura, Tomoaki Taguchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT. Methods: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus. Results: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications. Conclusions: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.

Original languageEnglish
Pages (from-to)672-678
Number of pages7
JournalPediatrics International
Volume61
Issue number7
DOIs
Publication statusPublished - Jul 1 2019

Fingerprint

Teratoma
Practice Guidelines
Guidelines
Interventional Radiology
Neoplasms
Fatal Outcome
Information Services
Information Dissemination
Disseminated Intravascular Coagulation
Germ Cell and Embryonal Neoplasms
PubMed
Paralysis
Cesarean Section
Leg
Consensus
Japan
Urinary Bladder
Language
Heart Failure
Quality of Life

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017. / Fumino, Shigehisa; Tajiri, Tatsuro; Usui, Noriaki; Tamura, Masanori; Sago, Haruhiko; Ono, Shigeru; Nosaka, Shunsuke; Yoneda, Akihiro; Souzaki, Ryota; Higashi, Mayumi; Sakai, Kohei; Takahashi, Ken; Sugiura, Takahiro; Taguchi, Tomoaki.

In: Pediatrics International, Vol. 61, No. 7, 01.07.2019, p. 672-678.

Research output: Contribution to journalArticle

Fumino, S, Tajiri, T, Usui, N, Tamura, M, Sago, H, Ono, S, Nosaka, S, Yoneda, A, Souzaki, R, Higashi, M, Sakai, K, Takahashi, K, Sugiura, T & Taguchi, T 2019, 'Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017', Pediatrics International, vol. 61, no. 7, pp. 672-678. https://doi.org/10.1111/ped.13844
Fumino S, Tajiri T, Usui N, Tamura M, Sago H, Ono S et al. Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017. Pediatrics International. 2019 Jul 1;61(7):672-678. https://doi.org/10.1111/ped.13844
Fumino, Shigehisa ; Tajiri, Tatsuro ; Usui, Noriaki ; Tamura, Masanori ; Sago, Haruhiko ; Ono, Shigeru ; Nosaka, Shunsuke ; Yoneda, Akihiro ; Souzaki, Ryota ; Higashi, Mayumi ; Sakai, Kohei ; Takahashi, Ken ; Sugiura, Takahiro ; Taguchi, Tomoaki. / Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017. In: Pediatrics International. 2019 ; Vol. 61, No. 7. pp. 672-678.
@article{8a48ffb67c514242b640ff4864dfe85b,
title = "Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017",
abstract = "Background: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT. Methods: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus. Results: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications. Conclusions: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.",
author = "Shigehisa Fumino and Tatsuro Tajiri and Noriaki Usui and Masanori Tamura and Haruhiko Sago and Shigeru Ono and Shunsuke Nosaka and Akihiro Yoneda and Ryota Souzaki and Mayumi Higashi and Kohei Sakai and Ken Takahashi and Takahiro Sugiura and Tomoaki Taguchi",
year = "2019",
month = "7",
day = "1",
doi = "10.1111/ped.13844",
language = "English",
volume = "61",
pages = "672--678",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017

AU - Fumino, Shigehisa

AU - Tajiri, Tatsuro

AU - Usui, Noriaki

AU - Tamura, Masanori

AU - Sago, Haruhiko

AU - Ono, Shigeru

AU - Nosaka, Shunsuke

AU - Yoneda, Akihiro

AU - Souzaki, Ryota

AU - Higashi, Mayumi

AU - Sakai, Kohei

AU - Takahashi, Ken

AU - Sugiura, Takahiro

AU - Taguchi, Tomoaki

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT. Methods: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus. Results: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications. Conclusions: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.

AB - Background: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT. Methods: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus. Results: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications. Conclusions: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.

UR - http://www.scopus.com/inward/record.url?scp=85067458117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067458117&partnerID=8YFLogxK

U2 - 10.1111/ped.13844

DO - 10.1111/ped.13844

M3 - Article

C2 - 30903638

AN - SCOPUS:85067458117

VL - 61

SP - 672

EP - 678

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 7

ER -